V Square Quantitative Management LLC cut its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 13.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 46,709 shares of the company's stock after selling 7,382 shares during the quarter. Procter & Gamble makes up about 0.7% of V Square Quantitative Management LLC's holdings, making the stock its 15th biggest position. V Square Quantitative Management LLC's holdings in Procter & Gamble were worth $6,694,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Halbert Hargrove Global Advisors LLC bought a new position in shares of Procter & Gamble in the third quarter valued at approximately $25,000. Maseco LLP bought a new stake in shares of Procter & Gamble during the 4th quarter worth $28,000. Saranac Partners Ltd purchased a new position in shares of Procter & Gamble in the 3rd quarter worth about $30,000. Corundum Trust Company INC bought a new position in Procter & Gamble during the third quarter valued at about $32,000. Finally, Caitlin John LLC purchased a new stake in Procter & Gamble during the third quarter worth about $34,000. Hedge funds and other institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Up 1.2%
Shares of NYSE:PG opened at $146.69 on Friday. The firm has a fifty day moving average price of $153.17 and a two-hundred day moving average price of $149.31. The company has a market cap of $340.90 billion, a price-to-earnings ratio of 21.73, a PEG ratio of 5.10 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51. Procter & Gamble Company has a one year low of $137.62 and a one year high of $171.65.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm had revenue of $22.21 billion for the quarter, compared to analysts' expectations of $22.36 billion. During the same quarter in the prior year, the firm posted $1.88 earnings per share. The business's quarterly revenue was up 1.5% on a year-over-year basis. Analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. Procter & Gamble's payout ratio is presently 62.52%.
Analyst Ratings Changes
A number of research firms have weighed in on PG. BNP Paribas Exane dropped their target price on shares of Procter & Gamble from $172.00 to $164.00 and set an "outperform" rating on the stock in a research note on Friday, January 16th. Erste Group Bank downgraded Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Tuesday, March 24th. Rothschild & Co Redburn increased their price target on Procter & Gamble from $155.00 to $157.00 and gave the stock a "neutral" rating in a research note on Friday, January 23rd. Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $177.00 to $158.00 and set an "overweight" rating on the stock in a research report on Wednesday. Finally, The Goldman Sachs Group cut their price target on Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a report on Wednesday. Twelve investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $164.26.
Read Our Latest Report on Procter & Gamble
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
Insiders Place Their Bets
In other news, Chairman Jon R. Moeller sold 162,232 shares of Procter & Gamble stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the sale, the chairman directly owned 319,385 shares of the company's stock, valued at approximately $51,884,093.25. The trade was a 33.68% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the company's stock in a transaction on Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the completion of the transaction, the insider owned 44,735 shares of the company's stock, valued at $7,259,595.80. This trade represents a 25.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 348,618 shares of company stock valued at $55,462,643 over the last three months. Corporate insiders own 0.20% of the company's stock.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.